Keyphrases
Melanoma
100%
GSK3 Signaling
100%
MTOR Complex 2 (mTORC2)
100%
Isoliquiritigenin
100%
Cachexia
100%
Mammalian Target of Rapamycin (mTOR)
25%
Cell Proliferation
16%
Human Melanoma Cells
16%
Glucose Uptake
16%
Tyrosinase Activity
16%
Melanin Content
16%
Lactate Level
16%
Flavonoids
8%
Signaling Pathway
8%
Specific Inhibitor
8%
Synergistic Effect
8%
MRNA Level
8%
Adenosine Triphosphate
8%
Cancer Cells
8%
In Cancer
8%
MRNA Expression
8%
Glucose Transporter 1 (GLUT1)
8%
Glycogen Synthase Kinase 3 (GSK3)
8%
AKT1
8%
Protein Expression Level
8%
Co-treatment
8%
Apoptosis Rate
8%
G2-M Cell Cycle Arrest
8%
Proliferation Inhibition
8%
A375 Cells
8%
Melanogenesis
8%
Anchorage-independent
8%
Terminal Differentiation
8%
O2 Consumption Rate
8%
Uptake Level
8%
Rictor
8%
KU-0063794
8%
Antitumor Activity in Vitro
8%
Induced Reprogramming
8%
Immunology and Microbiology
Cell Proliferation
100%
Glucose Transport
100%
Cell Cycle Arrest
50%
Cell Cycle Checkpoint
50%
Cancer Cell
50%
Antineoplastic Activity
50%
Protein Expression Level
50%
Melanoma Cell
50%
mRNA Expression Level
50%
Oxygen Consumption
50%
Melanogenesis
50%
Apoptosis Rate
50%
Medicine and Dentistry
Melanoma
100%
Isoliquiritigenin
100%
Cachexia
100%
Mammalian Target of Rapamycin
25%
Messenger RNA
16%
Cell Proliferation
16%
Glucose Uptake
16%
Lactic Acid
16%
Tyrosinase
16%
Melanin
16%
In Vitro
8%
Cell Cycle Checkpoint
8%
Cell Cycle Arrest
8%
Programmed Cell Death
8%
Cell Signaling Pathway
8%
Cancer Cell
8%
Flavonoid
8%
Protein Expression
8%
Antineoplastic Activity
8%
Glucose Transporter 1
8%
Adenosine Triphosphate
8%
Melanoma Cell
8%
Oxygen Consumption
8%
Melanogenesis
8%
5 [2 (2,6 Dimethylmorpholino) 4 morpholinopyrido[2,3 D]pyrimidin 7 Yl] 2 Methoxybenzenemethanol
8%
Anchorage
8%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Isoliquiritigenin
100%
Cachexia
100%
Messenger RNA
16%
Lactic Acid
16%
Tyrosinase
16%
Melanin
16%
Flavonoid
8%
Malignant Neoplasm
8%
Adenosine Triphosphate
8%
Antitumor Activity
8%
Glucose Transporter 1
8%
5 [2 (2,6 Dimethylmorpholino) 4 morpholinopyrido[2,3 D]pyrimidin 7 Yl] 2 Methoxybenzenemethanol
8%